Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells.

Having unique architectural features, cationic polymeric nanocapsules (NCs) with well-defined covalently stabilized biodegradable structures were generated as potentially universal and safe therapeutic nanocarriers. These NCs were synthesized from allyl-functionalized cationic polylactide (CPLA) by highly efficient UV-induced thiol-ene interfacial cross-linking in transparent miniemulsions. With tunable nanoscopic sizes, negligible cytotoxicity and remarkable degradability, they are able to encapsulate doxorubicin (Dox) with inner cavities and bind interleukin-8 (IL-8) small interfering RNA (siRNA) with cationic shells. The Dox-encapsulated NCs can effectively bypass the P-glycoprotein (Pgp)-mediated multidrug resistance of MCF7/ADR cancer cells, thereby resulting in increased intracellular drug concentration and reduced cell viability. In vitro studies also showed that the NCs loaded with Dox, IL-8 siRNA and both agents can be readily taken up by PC3 prostate cancer cells, resulting in a significant chemotherapeutic effect and/or IL-8 gene silencing.

[1]  Craig J Hawker,et al.  Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility. , 2006, Chemical Society reviews.

[2]  Nicholas A Peppas,et al.  A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  Jean Paul Remon,et al.  Polymeric multilayer capsules in drug delivery. , 2010, Angewandte Chemie.

[4]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[5]  J. Richie,et al.  Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Sunita Yadav,et al.  Multi-functional nanocarriers to overcome tumor drug resistance. , 2008, Cancer treatment reviews.

[7]  David A Tirrell,et al.  Core-clickable PEG-branch-azide bivalent-bottle-brush polymers by ROMP: grafting-through and clicking-to. , 2011, Journal of the American Chemical Society.

[8]  Yen Wah Tong,et al.  Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect. , 2009, Biomaterials.

[9]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[10]  Paras N. Prasad,et al.  Introduction to Nanomedicine and Nanobioengineering , 2012 .

[11]  Ravikumar Aalinkeel,et al.  Gene Expression of Angiogenic Factors Correlates with Metastatic Potential of Prostate Cancer Cells , 2004, Cancer Research.

[12]  Jun Wang,et al.  Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. , 2011, ACS nano.

[13]  Kurt E. Geckeler,et al.  Paclitaxel‐Loaded Polymer Nanoparticles for the Reversal of Multidrug Resistance in Breast Cancer Cells , 2011 .

[14]  Chen Jiang,et al.  Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer. , 2011, Biomaterials.

[15]  Chih-Kuang Chen,et al.  Clicking Well‐Defined Biodegradable Nanoparticles and Nanocapsules by UV‐Induced Thiol‐Ene Cross‐Linking in Transparent Miniemulsions , 2011, Advanced materials.

[16]  Ming Jiang,et al.  Synthesis of cationic polylactides with tunable charge densities as nanocarriers for effective gene delivery. , 2013, Molecular pharmaceutics.

[17]  F. Szoka,et al.  Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. , 2009, Accounts of chemical research.

[18]  V. S. Lin,et al.  Mesoporous silica nanoparticles deliver DNA and chemicals into plants. , 2007, Nature nanotechnology.

[19]  Ho Sup Yoon,et al.  Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer , 2006, Nature materials.

[20]  Jiwei Cui,et al.  Preparation of nano- and microcapsules by electrophoretic polymer assembly. , 2013, Angewandte Chemie.

[21]  W T Bellamy,et al.  P-glycoproteins and multidrug resistance. , 1996, Annual review of pharmacology and toxicology.

[22]  F. McCormick,et al.  Cancer gene therapy: fringe or cutting edge? , 2001, Nature Reviews Cancer.

[23]  Chong Cheng,et al.  Polyelectrolyte nanocages via crystallized miniemulsion droplets. , 2011, Chemical communications.

[24]  Nicholas A Peppas,et al.  Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance. , 2012, Nano today.

[25]  Zhan Yuin Ong,et al.  , Amalina Bte Ebrahim Attia , 2012 .

[26]  A. Oza,et al.  Clinical development of P glycoprotein modulators in oncology. , 2002, Novartis Foundation symposium.

[27]  D. Waugh,et al.  The Interleukin-8 Pathway in Cancer , 2008, Clinical Cancer Research.

[28]  Daniel W. Pack,et al.  Design and development of polymers for gene delivery , 2005, Nature Reviews Drug Discovery.

[29]  L. Fass.  Imaging and cancer: A review , 2008, Molecular oncology.

[30]  Edouard C. Nice,et al.  Bypassing Multidrug Resistance in Cancer Cells with Biodegradable Polymer Capsules , 2010, Advanced materials.

[31]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[32]  Nicolas Bertrand,et al.  The journey of a drug-carrier in the body: an anatomo-physiological perspective. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Honggang Cui,et al.  Supramolecular nanostructures formed by anticancer drug assembly. , 2013, Journal of the American Chemical Society.

[34]  Karen L Wooley,et al.  Cationic shell-crosslinked knedel-like nanoparticles for highly efficient gene and oligonucleotide transfection of mammalian cells. , 2009, Biomaterials.

[35]  Gediminas Mainelis,et al.  Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance , 2010, Proceedings of the National Academy of Sciences.

[36]  Karen L Wooley,et al.  Design of polymeric nanoparticles for biomedical delivery applications. , 2012, Chemical Society reviews.

[37]  Mauro Ferrari,et al.  Nanomedicine--challenge and perspectives. , 2009, Angewandte Chemie.

[38]  Chih-Kuang Chen,et al.  Well‐Defined Degradable Cationic Polylactide as Nanocarrier for the Delivery of siRNA to Silence Angiogenesis in Prostate Cancer , 2012, Advanced healthcare materials.

[39]  Katharina Landfester,et al.  From Polymeric Particles to Multifunctional Nanocapsules for Biomedical Applications Using the Miniemulsion Process , 2010 .

[40]  A. Elaissari,et al.  Nanotechnology olymer-based nanocapsules for drug delivery , 2009 .

[41]  Eleftheria Tsakalozou,et al.  Drug Release Patterns and Cytotoxicity of PEG-poly(aspartate) Block Copolymer Micelles in Cancer Cells , 2012, Pharmaceutical Research.

[42]  P. Johnston,et al.  Molecular mechanisms of drug resistance , 2005, The Journal of pathology.

[43]  Robert Langer,et al.  Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. , 2007, Nanomedicine.

[44]  B. Chabner,et al.  Chemotherapy and the war on cancer , 2005, Nature Reviews Cancer.

[45]  Nancy R. Sottos,et al.  Triggered Release from Polymer Capsules , 2011 .

[46]  J. Fletcher,et al.  ABC transporters in cancer: more than just drug efflux pumps , 2010, Nature Reviews Cancer.

[47]  D. Lasič,et al.  Doxorubicin in sterically stabilized liposomes , 1996, Nature.